Transplantation Proceedings
Volume 41, Issue 9 , Pages 3519-3528 , November 2009

Composite Tissue Allotransplantation: Current Challenges

  • K.V. Ravindra

      Affiliations

    • Department of Surgery, University of Louisville, Louisville, Kentucky
    • ,
  • S. Wu

      Affiliations

    • Institute for Cellular Therapeutics, University of Louisville, Louisville, Kentucky
    • ,
  • M. McKinney

      Affiliations

    • Institute for Cellular Therapeutics, University of Louisville, Louisville, Kentucky
    • ,
  • H. Xu

      Affiliations

    • Institute for Cellular Therapeutics, University of Louisville, Louisville, Kentucky
    • ,
  • S.T. Ildstad

      Affiliations

    • Department of Surgery, University of Louisville, Louisville, Kentucky
    • Corresponding Author InformationAddress reprint requests to Suzanne T. Ildstad, MD, Director, Institute for Cellular Therapeutics, Jewish Hospital Distinguished Professor of Transplantation, Distinguished University Scholar, Professor of Surgery, University of Louisville, 570 South Preston Street, Suite 404, Louisville, KY 40202-1760

References 

  1. Gander B, Brown CS, Vasilic D, et al. Composite tissue allotransplantation of the hand and face: a new frontier in transplant and reconstructive surgery. Transpl Int. 2006;19:868
  2. Da Varagine J. Leggenda Aurea. Florence, Italy: Libreria Editrice Fiorentina; 1952;
  3. Zeitlin , Ver Brugge . The sympathetic slave. In:  Gnudi MT,  Webster JP editor. The life and times of Gaspare Tagliacozzi, surgeon of Bologna, 1545–1599. New York: Herbert Reichner; 2008;p. 285
  4. Judet H. Essai sur la greffe des tissues articulaire. C R Seances Acad Sci III. 1908;146:193
  5. Lexer E. Substitution of whole or half joints from freshly amputated extremities by free plastic operation. Surg Gynecol Obstet. 1908;6:601
  6. Schwind JV. Successful transplantation of a leg in albineo rats with reestablishment of muscular control. Science. 1936;84:355
  7. Gilbert R. Transplant is successful with a cadaver forearm. Med Trib Med News. 1964;5:20
  8. Calne R, Moffatt SD, Friend PJ, et al. Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients. Transplantation. 1999;68:1613
  9. Calne RY, Rolles K, White DJ, et al. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet. 1978;1978:1323
  10. Tsamandas AC, Pham SM, Seaberg EC, et al. Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction. J Heart Lung Transplant. 1997;16:723
  11. Thomson AW, Carroll PB, McCauley J, et al. FK 506: a novel immunosuppressant for treatment of autoimmune disease (Rationale and preliminary clinical experience at the University of Pittsburgh). Springer Semin Immunopathol. 1993;14:323
  12. Markus PM, Cai X, Selvaggi G, et al. The effect of cyclosporine, rapamycin and FK 506 the survival following allogeneic bone marrow transplantation. Transplant Proc. 1991;23:3232
  13. Magee CC, Denton MD, Milford EL. Immunosuppressive agents in organ transplantation. Hosp Med. 1999;60:364
  14. Dubernard JM, Owen E, Herzberg G, et al. Human hand allograft: report on first 6 months. [see comments] Lancet. 1999;353:1315
  15. Jones JW, Gruber SA, Barker JH, et al. Successful hand transplantation: one-year follow-up (Louisville Hand Transplant Team). N Engl J Med. 2000;343:468
  16. Kanitakis J, Jullien D, Petruzzo P, et al. Clinicopathologic features of graft rejection of the first human hand allograft. Transplantation. 2003;76:688
  17. Ravindra K, Buell J, Kaufman C, et al. Steroid free immunosuppression in hand transplantation: first large series in world literature. Boston: American Transplant Congress; May 30–June 3, 2009;
  18. Dunn DL. Problems related to immunosuppression (Infection and malignancy occurring after solid organ transplantation). Crit Care Clin. 1990;6:955
  19. Gonzalez RN, Gorantla VS, Breidenbach WC. Complications after hand transplantation: Osteonecrosis of the hips [abstract] (World Society for Reconstructive Microsurgery (WSRM) III Congress, Part III). 2005;Buenos Aires, Argentina
  20. Dubernard JM, Lengele B, Morelon E, et al. Outcomes 18 months after the first human partial face transplantation. N Engl J Med. 2007;357:2451
  21. Hettiaratchy S, Randolph MA, Petit F, et al. Composite tissue allotransplantation-a new era in plastic surgery?. Br J Plast Surg. 2004;57:381
  22. Kouwenhoven EA, IJzermans JN, de Bruin RW. Etiology and pathophysiology of chronic transplant dysfunction. Transpl Int. 2000;13:385
  23. Lanzetta M, Petruzzo P, Margreiter R, et al. The International Registry on Hand and Composite Tissue Transplantation. Transplantation. 2005;79:1210
  24. Tobin GR, Breidenbach WC, Pidwell DJ, et al. Transplantation of the hand, face, and composite structures: evolution and current status. Clin Plast Surg. 2007;34:271
  25. Adamson LA, Huang W, Breidenbach WC, et al. A modified model of hindlimb osteomyocutaneous flap for the study of tolerance to composite tissue allotransplantation. Microsurgery. 2007;27:630
  26. Ildstad ST, Breidenbach WC. Tolerance to organ transplants: is chimerism bringing it closer than we think?. Curr Opin Organ Transplant. 2007;12:329
  27. Kanitakis J, Petruzzo P, Jullien D, et al. Pathological score for the evaluation of allograft rejection in human hand (composite tissue) allotransplantation. Eur J Dermatol. 2005;15:235
  28. Kanitakis J, Jullien D, Petruzzo P, et al. Immunohistologic studies of the skin of human hand allografts: our experience with two patients. Transplant Proc. 2001;33:1722
  29. Breidenbach W, Ravindra K, Buell J, et al. Update on the American hand transplant experience: five hand transplants performed at Louisville. [abstract] Boston: American Transplant Congress; May 30–June 3, 2009;
  30. Rossini AA, Greiner DL, Mordes JP. Induction of immunologic tolerance for transplantation. Physiol Rev. 1999;79:99
  31. Billingham RE, Lampkin HG, Medawar PB, et al. Tolerance of homografts, twin diagnosis and the freemartin conditions in cattle. Heredity. 1952;6:201
  32. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature. 1984;307:168
  33. Ildstad ST, Wren SM, Bluestone JA, et al. Characterization of mixed allogeneic chimeras: Immunocompetence, in vitro reactivity and genetic specificity of tolerance. J Exp Med. 1985;162:231
  34. Starzl TE, Demetris AJ, Murase N, et al. Cell migration, chimerism and graft acceptance. Lancet. 1992;339:1579
  35. Burlingham WJ. Chimerism after organ transplantation: is there any clinical significance?. Clin Transplant. 1996;10:110
  36. Starzl TE. Chimerism and tolerance in transplantation. Proc Natl Acad Sci USA. 2004;101(suppl 2):14607
  37. Starzl TE, Murase N, Thomson A, et al. Liver transplants contribute to their own success. Nat Med. 1996;2:163
  38. Schlitt HJ, Hundrieser J, Hisanaga M, et al. Patterns of donor-type microchimerism after heart transplantation. Lancet. 1994;343:1469
  39. Ishida H, Kawai T, Tanabe K, et al. Status of microchimerism in recipients 15 years after living related kidney transplantation. Transplantation. 1996;62:126
  40. Starzl TE, Zinkernagel RM. Transplantation tolerance from a historical perspective. Nat Rev Immunol. 2001;1:233
  41. Lukomska B, Durlik M, Cybulska E, et al. Comparative analysis of immunological reconstitution induced by vascularized bone marrow versus bone marrow cell transplantation. Transpl Int. 1996;9(suppl 1):S492
  42. Janczewska S, Ziolkowska A, Durlik M, et al. Fast lymphoid reconstitution after vascularized bone marrow transplantation in lethally irradiated rats. Transplantation. 1999;68:201
  43. Hewitt CW, Black KS, Dowdy SF, et al. Composite tissue (limb) allografts in rats (III. Development of donor-host lymphoid chimeras in long-term survivors). Transplantation. 1986;41:39
  44. Ohajekwe OA, Hardy MA, Oluwole SF. Prevention of graft-versus-host disease and the induction of transplant tolerance by low-dose UV-B irradiation of BM cells combined with cyclosporine immunosuppression. Transplantation. 1995;60:1510
  45. Llull R, Murase N, Ye Q, et al. Vascularized bone marrow transplantation in rats: evidence for amplification of hematolymphoid chimerism and freedom from graft-versus-host reaction. Transplant Proc. 1995;27:164
  46. Hewitt CW, Ramsamooj R, Patel MP, et al. Development of stable mixed T cell chimerism and transplantation tolerance without immune modulation in recipients of vascularized bone marrow allografts. Transplantation. 1990;50:766
  47. Gorantla VS, Prabhune KA, Perez-Abadia G, et al. Composite tissue allotransplantation in chimeric hosts: part I (Prevention of graft-versus-host disease). Transplantation. 2003;75:922
  48. Prabhune KA, Gorantla VS, Perez-Abadia G, et al. Composite tissue allotransplantation in chimeric hosts part II (A clinically relevant protocol to induce tolerance in a rat model). Transplantation. 2003;76:1548
  49. Brouha PC, Perez-Abadia G, Francois CG, et al. Lymphadenectomy prior to rat hind limb allotransplantation prevents graft-versus-host disease in chimeric hosts. Transpl Int. 2004;17:341
  50. Bourget JL, Mathes DW, Nielsen GP, et al. Tolerance to musculoskeletal allografts with transient lymphocyte chimerism in miniature swine. Transplantation. 2001;71:851
  51. Granger DK, Briedenbach WC, Pidwell DJ, et al. Lack of donor hyporesponsiveness and donor chimerism after clinical transplantation of the hand. Transplantation. 2002;74:1624
  52. Shimoni A, Hardan I, Shem-Tov N, et al. Fludarabine and treosulfan: a novel modified myeloablative regimen for allogeneic hematopoietic stem-cell transplantation with effective antileukemia activity in patients with acute myeloid leukemia and myelodysplastic syndromes. Leuk Lymphoma. 2007;48:2352
  53. Kolb H, Mittermuller J, Clemm C, et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood. 1990;76:2462
  54. Kolb HJ, Schattenberg A, Goldman JM, et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients (European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia). Blood. 1995;86:2041
  55. Barrett J, Childs R. New directions in allogeneic stem cell transplantation. Semin Hematol. 2002;39:1
  56. Luznik L, O'Donnell PV, Symons HJ, et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant. 2008;14:641
  57. Sykes M, Sachs DH. Mixed allogeneic chimerism as an approach to transplantation tolerance. Immunol Today. 1988;9:23
  58. Colson YL, Zadach KJ, Ildstad ST. Permanent drug-free cardiac allograft survival using a nonlethal approach to mixed bone marrow chimerism. Surgical Forum. 1994;50:242
  59. Colson YL, Zadach KJ, Ildstad ST. Mixed xenogeneic chimerism (mouse + rat −> mouse) induces cellular and humoral tolerance for primarily vascularized cardiac allografts. Surg Forum. 1995;46:241
  60. Pham SM, Mitruka SN, Youm W, et al. Mixed hematopoietic chimerism induces donor-specific tolerance for lung allografts in rodents. Am J Respir Crit Care Med. 1999;159:199
  61. Li H, Kaufman CL, Ildstad ST. Allogeneic chimerism induces donor-specific tolerance to simultaneous islet allografts in non-obese diabetic (NOD) mice. Surgery. 1995;118:192
  62. Gammie JS, Li S, Kawaharada N, et al. Mixed allogeneic chimerism prevents obstructive airway disease in a rat heterotopic tracheal transplant model. J Heart Lung Transplant. 1998;17:801
  63. Huang CA, Fuchimoto Y, Scheier-Dolberg R, et al. Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model. J Clin Invest. 2000;105:173
  64. Kawai T, Cosimi AB, Colvin RB, et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation. 1995;59:256
  65. Mache CJ, Schwinger W, Spendel S, et al. Skin transplantation to monitor clinical donor-related tolerance in mixed hematopoietic chimerism. Pediatr Transplant. 2006;10:128
  66. Trivedi HL, Vanikar AV, Modi PR, et al. Allogeneic hematopoietic stem-cell transplantation, mixed chimerism, and tolerance in living related donor renal allograft recipients. Transplant Proc. 2005;37:737
  67. Scandling JD, Busque S, Jbakhsh-Jones S, et al. Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med. 2008;358:362
  68. Gammie JS, Li S, Demetris AJ, et al. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts. Circulation. 1998;98:II163
  69. Ruedi E, Sykes M, Ildstad ST, et al. Antiviral T cell competence and restriction specificity of mixed allogeneic (P1 + P2 −> P1) irradiation chimeras. Cell Immunol. 1989;121:185
  70. Storb R, Leisenring W, Deeg HJ, et al. Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia. Blood. 1994;83:2749
  71. Munn RK, Henslee-Downey PJ, Romond EH, et al. Treatment of leukemia with partially matched related bone marrow transplantation. Bone Marrow Transplant. 1997;19:421
  72. Ferrara J, Deeg HJ. Graft-versus-host disease. N Engl J Med. 1991;324:667
  73. Vallera DA, Blazar BR. T cell depletion for graft-versus-host disease prophylaxis (A perspective on engraftment in mice and humans). Transplantation. 1989;47:751
  74. Reisner Y, Kapoor N, Kirkpatrick D, et al. Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet. 1981;2:327
  75. Kaufman CL, Colson YL, Wren SM, et al. Phenotypic characterization of a novel bone-marrow derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood. 1994;84:2436
  76. Jacquet EG, Schanie CL, Fugier-Vivier I, et al. Facilitating cells as a venue to establish mixed chimerism and tolerance. Pediatr Transplant. 2003;7:348
  77. Fugier-Vivier I, Rezzoug F, Huang Y, et al. Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment. J Exp Med. 2005;201:373
  78. Fehervari Z, Sakaguchi S. CD4+ Tregs and immune control. J Clin Invest. 2004;114:1209
  79. Sakaguchi S, Sakaguchi N, Shimizu J, et al. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev. 2001;182:18
  80. Sakaguchi S, Hori S, Fukui Y, et al. Thymic generation and selection of CD25+CD4+ regulatory T cells: implications of their broad repertoire and high self-reactivity for the maintenance of immunological self-tolerance. Novartis Found Symp. 2003;252:6
  81. Di IM, Del PB, Cecchini D, et al. Immunomagnetic isolation of CD4+CD25+FoxP3+ natural T regulatory lymphocytes for clinical applications. Clin Exp Immunol. 2009;156:246
  82. Baecher-Allan C, Brown JA, Freeman GJ, et al. CD4(+)CD25(high) regulatory cells in human peripheral blood. J Immunol. 2001;167:1245
  83. Wing K, Fehervari Z, Sakaguchi S. Emerging possibilities in the development and function of regulatory T cells. Int Immunol. 2006;18:991
  84. Sakaguchi S, Ono M, Setoguchi R, et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev. 2006;212:8
  85. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol. 2008;8:523
  86. Morris GP, Brown NK, Kong YC. Naturally-existing CD4(+)CD25(+)Foxp3(+) regulatory T cells are required for tolerance to experimental autoimmune thyroiditis induced by either exogenous or endogenous autoantigen. J Autoimmun. 2009;33:68
  87. Ziegler SF. FOXP3: of mice and men. Annu Rev Immunol. 2006;24:209
  88. Allan SE, Passerini L, Bacchetta R, et al. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J Clin Invest. 2005;115:3276
  89. Seidel MG, Ernst U, Printz D, et al. Expression of the putatively regulatory T-cell marker FOXP3 by CD4(+)CD25+ T cells after pediatric hematopoietic stem cell transplantation. Haematologica. 2006;91:566
  90. Clark FJ, Gregg R, Piper K, et al. Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cells. Blood. 2004;103:2410
  91. Sanchez J, Casano J, Alvarez MA, et al. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation. Br J Haematol. 2004;126:697
  92. Zorn E. CD4+CD25+ regulatory T cells in human hematopoietic cell transplantation. Semin Cancer Biol. 2006;16:150
  93. Eljaafari A, Badet L, Kanitakis J, et al. Isolation of regulatory T cells in the skin of a human hand-allograft, up to six years posttransplantation. Transplantation. 2006;82:1764
  94. Joffre O, Santolaria T, Calise D, et al. Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat Med. 2008;14:88
  95. Hirahara K, Liu L, Clark RA, et al. The majority of human peripheral blood CD4+CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors. J Immunol. 2006;177:4488
  96. Liu W, Putnam AL, Xu-Yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med. 2006;203:1701
  97. Xu H, Chilton PM, Huang Y, et al. Addition of cyclophosphamide to T-cell depletion based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation. Transplantation. 2007;83:954
  98. Tokunaga M, Miyamura K, Ohashi H, et al. Successful nonmyeloablative bone marrow transplantation for leukocyte adhesion deficiency type I from an unrelated donor. Int J Hematol. 2007;86:91
  99. Wood ML, Monaco AP, Gozzo JJ, et al. Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing. Transplant Proc. 1971;3:676
  100. Colson YL, Xu H, Huang Y, et al. Mixed xenogeneic chimerism induces donor-specific humoral and cellular immune tolerance for cardiac xenografts. J Immunol. 2004;173:5827
  101. Code of Federal Regulations Title 21, Part 312, Sections 50–70 (21CFR 312.50–70); Responsibilities of sponsors and investigators
  102. Ozer K, Oke R, Gurunluoglu R, et al. Induction of tolerance to hind limb allografts in rats receiving cyclosporine A and antilymphocyte serum: effect of duration of the treatment. Transplantation. 2003;75:31
  103. Wekerle T, Kurtz J, Ito H, et al. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med. 2000;6:464
  104. Foster RD, Pham S, Li S, et al. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade. Transplantation. 2003;76:988
  105. Sandmaier BM, Bethge WA, Wilbur DS, et al. Bismuth 213-labeled anti-CD45 radioimmuno-conjugate to condition dogs for nonmyeloablative allogeneic marrow grafts. Blood. 2002;100:318
  106. Spitzer TR. Nonmyeloablative allogeneic stem cell transplant strategies and the role of mixed chimerism. Oncologist. 2000;5:215
  107. Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med. 2008;358:353

 Supported in part by NIH R01 DK069766 and NIH 5RO1 HL063442; JDRF 1-2005-1037 and JDRF 1-2006-1466; The Department of the Navy, Office of Naval Research; The Department of the Army, Office of Army Research. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the Office of Army Research. This publication was made possible by Award No. W81XWH-07-1-0185 from the Office of Army Research; the National Foundation to Support Cell Transplant Research; the Commonwealth of Kentucky Research Challenge Trust Fund; the W. M. Keck Foundation; and The Jewish Hospital Foundation.

PII: S0041-1345(09)01305-0

doi: 10.1016/j.transproceed.2009.08.052

Transplantation Proceedings
Volume 41, Issue 9 , Pages 3519-3528 , November 2009

Article Tools

* Image Usage & Resolution